Premature cell differentiation leads to disorders in pancreatic development

April 11, 2017, University of Helsinki
In the photo on the left, the cells are in middle of the differentiation process (red is insulin, green glucagon, blue DNA). In the photo on the right, the cells have nearly completed their differentiation and are grouped together in clumps of cells similar to pancreatic islets (red is insulin, green chromogranin and blue DNA). Credit: Otonkoski Lab / University of Helsinki

Researchers at the University of Helsinki, Finland, have uncovered a mechanism through which a mutation in the STAT3 gene leads to a disorder in the development of the pancreas and to infant diabetes.

Neonatal diabetes mellitus (NDM), or diabetes among infants less than six months of age, is a rare form of diabetes caused by a mutation in genes crusial to the development or function of . In about half of such cases, the disease becomes permanent (PNDM). Mutations in more than 20 genes have thus far been identified as causing the permanent variety of neonatal diabetes.

Unlike in type 1 diabetes, NDM patients typically do not have the autoantibodies normally associated with diabetes. However, it was recently discovered that mutations which activate the STAT3 gene may result in neonatal diabetes that includes a strong autoimmune phenomenon.

The mutation that activated the STAT gene most intensely (K392R) was found to cause the most severe form of . The mutation was discovered in 2014 in a Finnish patient, who had high levels of beta cell antibodies at birth and underdeveloped pancreas. The patient later developed several autoimmune manifestations in different organs.

A new study, led by Professor Timo Otonkoski, examined the impact the STAT3 mutation has on the development of the pancreas by using induced (iPS) derived from the patient's . The study was published in Cell Reports.

The iPS cells produced from the skin cells were made to differentiate into through a complex in vitro method that mirrors the normal development of the pancreas in humans. Before differentiation, the point mutation in the patient cells was repaired using CRISPR-CAS9 genome editing. After this, it was possible to compare the differentiation of the patient's cells during pancreatic development in two kinds of genetically similar cells: ones sick carrying the disease mutation and ones made healthy after being repaired through genome editing.

The results showed that the mutated STAT3 protein produced by the patient's cells led to the premature differentiation of the pancreatic progenitor cells into endocrine cells that produce insulin or glucagon. The results were clearly apparent in both cell cultures and in cells transplanted to mice, which allowed the researchers to study the development of the for much longer.

"The impact of the mutated STAT3 protein mechanism we discovered accounts for the underdeveloped pancreas and the early onset of diabetes, even without the damage done by autoimmune mechanisms," states Jonna Saarimäki-Vire, postdoctoral researcher and first author of the article.

Professor Otonkoski and researcher Diego Balboa, who was in charge of genome editing, point out that even though the mutation is rare, the study has broader impact.

"These results reveal the previously unknown significance of the STAT3 gene to pancreatic development. We also successfully used new stem cell technologies and methods that enable high-precision analysis of the mechanisms underlying disease . We intend to use the same approach to study other diabetes genes in the future."

Explore further: Genetic mutation during embryonic development could hold the key to a lifetime living with diabetes

More information: Saarimäki-Vire, Balboa et al. An activating STAT3 mutation causes neonatal diabetes through premature induction of pancreatic differentiation. Cell Reports 11 April 2017 (online). DOI: 10.1016/j.celrep.2017.03.055

Related Stories

Genetic mutation during embryonic development could hold the key to a lifetime living with diabetes

August 24, 2016
Personalized treatment for people with diabetes could be a step closer after researchers discovered how a single gene mutation fundamentally alters pancreatic development.

Unique mapping of methylome in insulin-producing islets

January 30, 2017
Throughout our lives, our genes are affected by the way we live. Diet, exercise, age and diseases create imprints that are stored in something called methylome. Now, for the first time, researchers at the Lund University ...

Protein packaging may cause the immune attacks of type 1 diabetes

November 21, 2016
Type-1 diabetes occurs when immune cells attack the pancreas. EPFL scientists have now discovered what may trigger this attack, opening new directions for treatments.

Low thyroid hormone before birth alters growth and development of fetal pancreas

February 1, 2017
Levels of thyroid hormone in babies influence insulin-secreting cells of the pancreas, according to a new study published in the Journal of Physiology.

Scientists study how some insulin-producing cells survive in type 1 diabetes

February 9, 2017
A Yale-led research team identified how insulin-producing cells that are typically destroyed in type 1 diabetes can change in order to survive immune attack. The finding may lead to strategies for recovering these cells in ...

New cause of diabetes

February 18, 2016
Although insulin-producing cells are found in the endocrine tissue of the pancreas, a new mouse study suggests that abnormalities in the exocrine tissue could cause cell non-autonomous effects that promotes diabetes-like ...

Recommended for you

Fat tissue may play a crucial role in the progression of diabetes, challenging long established notions

October 12, 2018
A new study by Australian researchers, out today, is challenging what we know about the causes of diabetes. The new research points to fat tissue as a source of disease, and widens our understanding beyond the traditional ...

Does breastfeeding hormone protect against type 2 diabetes?

October 12, 2018
(HealthDay)—The hormone prolactin—most commonly associated with breastfeeding—may play a role in reducing the risk of type 2 diabetes, a new study suggests.

Planned intermittent fasting may help reverse type 2 diabetes, suggest doctors

October 10, 2018
Planned intermittent fasting may help to reverse type 2 diabetes, suggest doctors writing in the journal BMJ Case Reports after three patients in their care, who did this, were able to cut out the need for insulin treatment ...

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

New discovery restores insulin cell function in type 2 diabetes

October 8, 2018
By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown ...

Weight loss drug shows positive effect on diabetes

October 4, 2018
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction (TIMI) Study Group presented diabetes-related findings from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.